Clinical Trial Update: Complement Regulatory Proteins Expression and Clinical Response in Rheumatoid Arthritis (RA) Patients Treated With Rituximab

View source ↗

Summary

A clinical trial update examining complement regulatory protein expression and clinical response in rheumatoid arthritis patients treated with rituximab; no sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Rheumatoid Arthritis | Status: UNKNOWN